Effect of Topiroxostat on Urinary Albumin in hyperuricemic patients with Diabetic nephropathy
Phase of Trial: Phase IV
Latest Information Update: 03 Apr 2019
Price : $35 *
At a glance
- Drugs Topiroxostat (Primary)
- Indications Diabetic nephropathies; Hyperuricaemia
- Focus Therapeutic Use
- Acronyms ETUDE
- 26 Oct 2017 Status changed from active, no longer recruiting to completed.
- 12 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 17 Oct 2014 New trial record